SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hydron Tech.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward Goldstein who wrote (26)5/19/1997 9:53:00 PM
From: Dave K   of 72
 
Hydron Technologies, Inc. Expects Record Sales in 2nd Quarter 1997
BOCA RATON, Fla., May 19 /PRNewswire/ -- Hydron Technologies, Inc.
(Nasdaq: HTEC) "HyTech," announced today that based upon current
orders in house and anticipated orders, it expects a record second
quarter in sales, which will be a substantial increase over the $2
million in sales recorded in the second quarter of 1996. Management
also expects a satisfactory profit for the second quarter despite
heavy expenses being incurred as it continues to expand its direct
marketing business.
Harvey Tauman, Chairman and President of HyTech said, "Year to
date, sales to consumers through the combination of direct response
television by our licensee and our own direct marketing operations
are approximately 40% ahead of last year. Based upon current
business trends, HyTech expects to have record sales in 1997."
The foregoing was a forward looking statement based upon
assumptions which appear reasonable at this time. No obligation
exists for HyTech's licensee for direct response television to make
any purchases, and therefore no assurance can be given that HyTech
will have record sales. As previously disclosed, HyTech and such
licensee are negotiating to further amend their License Agreement.
Although management is of the belief that an agreement to further
amend the License Agreement will be reached, no assurances can be
given that such will happen.
As previously announced, HyTech will begin selling its new line
of vitamins and nutritional supplements this quarter, and will also
begin to market the new patented nutritional supplement containing
the combination of Glucosamine and Chondroitin, under the name
"Cartilage Formula" in this quarter.
Hydron Technologies develops a broad range of personal care
products, including skin care, hair care, bath and body, and topical
over-the-counter pharmaceutical products, based on its proprietary
and patented Hydron polymer technology and now has added vitamin and
nutritional supplements to complement its existing business. The
company markets its products through direct response television and
by catalog. Catalogs are available by calling 800-4-HYDRON.
SOURCE Hydron Technologies, Inc.
-0- 5/19/97

/CONTACT: April Spring, Hydron Technologies, 561-994-6191, ext.
105/
/Other Hydron Technologies press releases are available through
Company News On-Call by fax, 800-758-5804, extension 238581, or at
prnewswire.com
(HTEC)

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext